Lario Raises $2.4M for Brain-Targeted Drugs
Lario, a startup focused on neurology and longevity, has raised $2.4 million in a recent funding round. The company is developing drugs that can be targeted specifically to the brain. The investment is a marker of growing interest in the intersection of personalized medicine, neurology, and longevity.
- The recent $2.4 million in grant funding for Lario came from two major non-profit research foundations: $1.5 million from The Michael J. Fox Foundation for Parkinson's Research and $900,000 from Wellcome. This funding is aimed at advancing Lario's work on small-molecule inhibitors that target specific neuronal calcium channels linked to Parkinson's disease and PTSD. - Lario's scientific approach focuses on voltage-gated neuronal calcium channels, such as CaV1.3 and CaV2.3, which are genetically linked to neurological diseases. This precision-medicine strategy aims to correct the specific malfunctions in brain circuits, rather than broadly suppressing or stimulating neural activity, which is a common issue with existing treatments. - The digital health market saw a significant rebound in 2025, with U.S. startups raising $14.2 billion, a 35% increase from 2024. This growth was largely driven by mega-deals of over $100 million and a strong investor focus on AI-enabled platforms, which captured 54% of total funding. - Successful consumer health apps like Flo and Noom leverage multi-faceted growth strategies. Flo, with over 70 million monthly active users, focuses on community-building through features like "Secret Chats" and has expanded its user base with a "Flo for Partners" feature. Noom utilizes a robust influencer and affiliate marketing program, offering commissions and unique coupon codes to drive user acquisition. - For consumer health apps, integrating with wearable devices is key for user engagement and personalization, with developers prioritizing Apple HealthKit for its broad data access on iOS, and APIs from Garmin, Oura, and Fitbit for more specific athletic, sleep, and recovery metrics. However, this often requires building native mobile apps, as platforms like Apple's HealthKit do not offer a cloud-based API and store data locally on the user's device. - Navigating health data privacy is a major challenge, as most consumer health apps and wearables are not directly covered by HIPAA. Instead, they fall under the FTC's Health Breach Notification Rule and various state privacy laws, making a transparent privacy policy and features like Flo's "anonymous mode" crucial for building trust with users. - The transition from a developer or clinician to a health tech CEO often involves seeking out co-founders with complementary business skills. For instance, Sujal Patel, a software entrepreneur who sold his previous company for $2.25 billion, spent his first year as CEO of biotech firm Nautilus catching up on basic biology and chemistry by watching college-level courses on YouTube. - Understanding the patient journey is critical for building a successful consumer health app. Chronic illness bloggers and patient advocates highlight the need for tools that help manage daily life, navigate the healthcare system, and provide a sense of community to combat the isolation that often comes with a diagnosis. Many patients express a desire for resources that acknowledge both the good and bad days of living with a chronic condition.
